WASHINGTON — President Trump signed an executive order Thursday directing the federal government to buy certain drugs solely from American factories.

The so-called “Buy American” order could represent a seismic shakeup of the drug industry: No one knows exactly how much of the American drug supply chain is produced abroad, but some experts insist up to 90% of critical generic drugs are made at least partially abroad.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I have been a hospital/health-system for many years, worked at a GPO and also in PhRMA industry and knew that there would be a price to pay, if we brought all the manufacturing back to the US. About 20 years ago, there was an anti-hypertensive drug we used for high risk pregnancy hypertension and the one manufacturer of the generic drug stopped making it, because they couldn’t make money. The physicians and I knew, after the OB-GYN National group petitioned, that we would pay more for this generic drug, but we needed it. I had a CMO from an ACO ask me once, “What is the Fair Value of a Drug? No one would object to paying that, if we can determine.”

    • Fred: There is an answer to the question “what is the fair value?” if more than one drug manufacturers were able to sell directly to the patient as it happens in any other business. However, in the Pharma world, drug sales are channeled by the PBMs (pharmacy benefit managers) and insurance companies. They get commissions from the manufacturer and the seller and also they decide whose product will be sold. Thus, no one in our mutually subsidized system knows the price of the drug except for copay.

      If the drug makers were able to sell directly to patients, competition will set the fair value price. Manufactuirng technology innovation will be there for quality drugs.

      One can reverse calculate the price of drugs and see how supply chain jacks up and dictates who sells to them.

      Just for example: ONE KILO of Metformin Hydrochloride at active ingredient level sells for about $4.00 per kilo and the manufacturer has his profiting it. Formulator converts it in tablets and lets say his conversion cost is FIVE time the cost of bulk API. Thus ONE KILO metformin (which makes about 2,000 tablets) after formulator’s profit would sell for $20.00 which means each tablet should sell for $0.01 per tablet. However, at Walmart 180 tablets for 90 day supply (500, 850 & 1000 mg) sell for $10.00 irrespective of dosage. That tells us that Walmart makes more money selling 500 mg tablets vs. 1000 mg tablet. Similar calculations can be done for other drugs. Table 3 of the linked http://bit.ly/2NCDITU shows us US prices of Ciprofloxacin.

      My point is that NO one in US knows the fair price and the reality has been highjacked by PBMs and insurance middle men. Proof is FOUR PBMs make the top 10 Fortune 500 list.

      Be safe and well.

  • How is that going to cost more for Americans when they are already paying over 200 times more than country next door like Canada? It’s time, to hit those greedy CEOs whose priority is their stock prices come first.

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy